Search

Your search keyword '"Yoshihara, Tsutomu"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Yoshihara, Tsutomu" Remove constraint Author: "Yoshihara, Tsutomu"
225 results on '"Yoshihara, Tsutomu"'

Search Results

3. Exploratory, multicenter, open-label study to evaluate the effects of linaclotide in patients with chronic constipation with an insufficient response to magnesium oxide: A study protocol

4. Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipation

5. Efficacy and safety of linaclotide in treatment‐resistant chronic constipation: A multicenter, open‐label study.

6. A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care Setting.

8. The Prevalence and Characteristics of Symptomatic Uncomplicated Diverticular Disease Among Asian Patients With Unexplained Abdominal Symptoms

10. Strain-level detection of Fusobacterium nucleatum in colorectal cancer specimens by targeting the CRISPR–Cas region

11. Natural History of Chronic Intestinal Pseudo-obstruction and Need for Palliative Care

14. Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study

16. Continued Use of a Single Antiplatelet Agent Does Not Increase the Risk of Delayed Bleeding After Colorectal Endoscopic Submucosal Dissection

17. Prior appendectomy and cerebral infarction as potential risk factors for recurrent ischemic colitis: A retrospective observational study.

19. Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase Ⅱa exploratory trial

20. Clinicopathological features of endoscopically treated early gastric cancer with lymphovascular infiltration

21. Effect of Bifidobacterium bifidum G9-1 on fecal short chain fatty acids in patients with chronic constipation: a multicenter, observational study

22. Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial

23. Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation

24. Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled Trial

25. Prior appendectomy and cerebral infarction as potential risk factors for recurrent ischemic colitis: a case control study

26. Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake

27. Efficacy of sedation with dexmedetomidine plus propofol during esophageal endoscopic submucosal dissection

28. Effects of colorectal endoscopic submucosal dissection on postoperative abdominal symptoms: a prospective observational study

29. Efficacy of Bifidobacterium bifidum G9-1 in improving quality of life in patients with chronic constipation: a prospective intervention study

30. Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype

31. The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota

32. The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin

33. Tu1100 THE COMPARISON OF DIAGNOSTIC ACCURACY ABOUT CORORECTAL NEOPLASM BETWEEN NARROW BAND IMAGING (NBI) AND BLUE LASER IMAGING (BLII) AND BLUE LIGHT IMAGING (BLII) MAGNIFYNG OBSERVATION USING JNET CLASSIFICATION: RANDOMIZED CONTROLLED TRIAL

34. Tu1781 AKKERMANSIA MUCINIPHILA AND BIFIDOBACTERIUM BIFIDUM G9-1: KEY PLAYERS IN SMALL INTESTINAL INJURY CAUSED BY THE COMBINATION OF ASPIRIN AND PROTON PUMP INHIBITORS

37. Clinical impact of evaluation of frailty in endoscopic submucosal dissection for early gastric cancer in elderly patients

38. Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: A proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study

39. The efficacy of Bifidobacterium bifidum G9-1 in improving quality of life in patients with chronic constipation

41. Relationship between Stool Form and Quality of Life in Patients with Chronic Constipation: An Internet Questionnaire Survey

42. Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: A proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study

43. Investigation of the Local Recurrence Rate after Colorectal Endoscopic Mucosal Resection: Is Incomplete Polyp Resection Really a Clinically Important Problem? Analysis of the Rationale for the “Resect and Discard” Strategy

44. Relationship between Stool Form and Quality of Life in Patients with Chronic Constipation: An Internet Questionnaire Survey.

46. Design of a Luenberger observer based sensorless multi-loop control for boost converters

47. The protective effect of Bifidobacterium bifidumG9-1 against mucus degradation by Akkermansia muciniphilafollowing small intestine injury caused by a proton pump inhibitor and aspirin

Catalog

Books, media, physical & digital resources